Skip to main content
. 2019 May 23;13:837–852. doi: 10.2147/PPA.S197481

Table 3A.

Differences in medication adherence, beliefs about medication, and clinical outcome between usual care and intervention groups at baseline, after intervention and at follow-up of 12 months (all after imputation)

Group I+II Usual care (UC)
N=271
Group II UC+consultations
N=148
p-valuea
Mean possesion ratiob
Total of cardiovascular medication
 Baseline (T1) 0.74 0.73
 After intervention (T2) 0.93 0.89 0.08
 Follow up of 12 months (T3) 0.81 0.76 0.23
Per ATC-code
 Baseline (T1)
  Antithrombotic agents (B01) 0.77 0.73
  Diuretics (C03) 0.79 0.73
  Beta blocking agents (C07) 0.87 0.83
  Calcium channel blockers (C08) 0.95 0.94
  Agents acting angiotensin (C09) 0.80 0.79
  Lipid modifying agents (C10) 0.80 0.76
After intervention (T2)
  Antithrombotic agents (B01) 0.92 0.91 0.65
  Diuretics (C03) 0.88 0.82 0.40
  Beta blocking agents (C07) 0.91 0.91 0.89
  Calcium channel blockers (C08) 0.89 0.87 0.57
  Agents acting angiotensin (C09) 0.92 0.91 0.56
  Lipid modifying agents (C10) 0.90 0.89 0.06
Follow up of 12 months (T3)
  Antithrombotic agents (B01) 0.86 0.82 0.27
  Diuretics (C03) 0.83 0.76 0.12
  Beta blocking agents (C07) 0.80 0.80 0.87
  Calcium channel blockers (C08) 0.93 0.91 0.34
  Agents acting angiotensin (C09) 0.84 0.80 0.48
  Lipid modifying agents (C10) 0.84 0.78 0.06
Adherentc
  Baseline (T1) 53.5 48
  After intervention (T2) 86.3 76.4 0.17
  Follow up of 12 months (T3) 64.9 76.4 0.38
Modified Morisky Scaled
 Baseline (T1)
  Low 19.6 21.6
  Medium 46.5 41.2
  High 32.7 37.2
 After intervention (T2)
  Low 28.7 31 0.94e
  Medium 38 38.5
  High 33.3 30.5
Beliefs about medication questionnaire
 Necessity concern differentialf
  Baseline (T1) 3.7 3.4
  After intervention (T2) 3.8 3.9 0.86
Categoriesg
 Baseline (T1)
  Accepting 27.3 25
  Ambivalent 62.7 60.1
  Sceptical 4.4 5.4
  Indifferent 5.5 9.5
 After intervention (T2)
  Accepting 26.6 32.8
  Ambivalent 43.2 37.1
  Sceptical 14.8 17.6
  Indifferent 15.2 12.6
Clinical outcomes
 Systolic blood pressure (mmHg)
  Baseline (T1) 136.4 136.7
  After intervention (T2) 155 155 0.71
  Adherenth 25 20.9 0.52
 Low- density cholestrol (mmol/L)
  Baseline (T1) 2.5 2.5
  After intervention (T2) 2.2 2.2 0.74
  Adherenti 90.4 86.4 0.4

Notes: aUsual care and usual care + are combined and compared with usual care ++ group. bMean number of days dispended divided by the mean number of days between prescription refill. cPercentage of patients (%) considered adherent according to PRD total of the cardiovascular medication (PRD was above or equal to 0.8). dPercentage of patients (%) who had low, medium, or high adherent scores. eLow and medium adherence are combined and compared with high adherence group. fDifferences between concern and necessity scores (means). gPercentage of patients (%) who are classified in the four different categories of the BMQ. hPercentage of patients (%) considered adherent according to systolic blood pressure (<135 mmHg) and percentage (%) of patients using antihypertension drugs. iPercentage of patients (%) considered adherent according to LDL level (the recorded LDL level after intervention was 20% lower of baseline LDL cholesterol).